Eye Vis (Lond). 2015 Oct 25;2:18. doi: 10.1186/s40662-015-0028-0. eCollection 2015.
Development and validation of a novel PCR-RFLP based method for the detection of 3 primary mitochondrial mutations in Leber's hereditary optic neuropathy patients.
Eye and vision (London, England)
Siobhan Eustace Ryan, Fergus Ryan, David Barton, Veronica O'Dwyer, Derek Neylan
Affiliations
Affiliations
- National Optometry Centre, Dublin Institute of Technology, Kevin Street, Dublin 8, Ireland.
- School of Biological Sciences, Dublin Institute of Technology, Kevin Street, Dublin 8, Ireland.
- Centre for Medical Genetics, Our Lady's Hospital for Sick Children, Crumlin, Dublin 12, Ireland.
PMID: 26605371
PMCID: PMC4657363 DOI: 10.1186/s40662-015-0028-0
Abstract
BACKGROUND: Leber's Hereditary Optic Neuropathy (LHON; MIM 535000) is one of the most commonly inherited optic neuropathies and it results in significant visual morbidity among young adults with a peak age of onset between the ages of 15-30. The worldwide incidence of LHON is approximately 1 in 31,000. 95 % of LHON patients will have one of 3 primary mitochondrial mutations, G3460A (A52T of ND1), G11778A (R340H of ND4) and T14484C (M64V of ND6). There is incomplete penetrance and a marked gender bias in the development of visual morbidity with approximately 50 % of male carriers and 10 % of female carriers developing optic neuropathy. Visual recovery can occur but is dependent on the mutation present with the highest level of visual recovery seen in patients who have the T14484C mutation. The 3 primary mutations are typically identified by individual end-point PCR-restriction fragment length polymorphism (RFLP) or individual targeted bi-directional Sanger sequencing reactions. The purpose of this study was to design a simple multiplex PCR-RFLP that could detect these 3 primary LHON mutations in one assay.
METHODS: PCR primers were designed to incorporate a MaeIII restriction site in the presence of 3460A and 14484C mutations with the 11778A mutation naturally incorporating a MaeIII site. A multiplex PCR-RFLP assay was developed to detect the 3 common mutations in a single assay. Synthetic LHON controls based on the mitochondrial genome harbouring the 3 common mutations were synthesized and cloned into plasmids to act as reliable assay controls. DNA from previously tested patients and the synthetic LHON controls were subjected to the multiplex PCR-RFLP assay. The RFLP products were detected by agarose gel electrophoresis.
RESULTS: The novel PCR-RFLP assay accurately detects the 3 primary mutations both in patient DNA and in synthesized DNA control samples with a simple visual mutation detection procedure. The synthesized DNA was demonstrated to be a robust control for the detection of LHON Mutations.
CONCLUSION: In this paper, we describe a novel, robust and simple PCR-RFLP based method for the detection of mutations causing LHON, and report the generation of a series of LHON DNA controls suitable for all currently published assays.
Keywords: LHON; Mitochondrial mutations; Multiplex PCR; Mutation detection; Visual morbidity
References
- Am J Hum Genet. 1996 Apr;58(4):703-11 - PubMed
- J Clin Neuroophthalmol. 1992 Mar;12(1):15-6 - PubMed
- Curr Treat Options Neurol. 2011 Feb;13(1):109-17 - PubMed
- Eur J Hum Genet. 2007 Oct;15(10):1079-89 - PubMed
- Brain. 2001 Jan;124(Pt 1):209-18 - PubMed
- Hum Mutat. 2013 Jun;34(6):882-93 - PubMed
- Orphanet J Rare Dis. 2014 Oct 23;9:158 - PubMed
- Clin Chim Acta. 2010 Nov 11;411(21-22):1671-4 - PubMed
- Biochem Biophys Res Commun. 1992 Sep 30;187(3):1551-7 - PubMed
- Biochem Biophys Res Commun. 1997 May 19;234(2):511-5 - PubMed
- Science. 1988 Dec 9;242(4884):1427-30 - PubMed
- J Med Genet. 2009 Mar;46(3):145-58 - PubMed
- Am J Hum Genet. 1995 Jul;57(1):77-86 - PubMed
- Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4778-88 - PubMed
- Am J Ophthalmol. 2006 Apr;141(4):676-82 - PubMed
- Intern Med J. 2004 Jan-Feb;34(1-2):10-9 - PubMed
- J Zhejiang Univ Sci B. 2008 Aug;9(8):610-5 - PubMed
- Am J Hum Genet. 1993 Oct;53(4):959-63 - PubMed
- Genet Test. 2005 Fall;9(3):190-9 - PubMed
- Arch Ophthalmol. 1993 Apr;111(4):495-8 - PubMed
- Arch Ophthalmol. 1998 Jul;116(7):911-6 - PubMed
- Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6206-10 - PubMed
- Arch Ophthalmol. 1992 Nov;110(11):1577-81 - PubMed
- Am J Ophthalmol. 2000 Dec;130(6):803-12 - PubMed
- Arch Ophthalmol. 1993 Nov;111(11):1491-4 - PubMed
- J Med Genet. 1995 Feb;32(2):81-7 - PubMed
- Am J Hum Genet. 2003 Feb;72(2):333-9 - PubMed
- Br J Ophthalmol. 1999 May;83(5):577-81 - PubMed
- Am J Hum Genet. 1998 Jan;62(1):196-202 - PubMed
- Invest Ophthalmol Vis Sci. 2014 Mar 06;55(3):1321-31 - PubMed
- Am J Ophthalmol. 1991 Jun 15;111(6):750-62 - PubMed
- Am J Hum Genet. 1991 Nov;49(5):939-50 - PubMed
Publication Types